[1]	Includes an aggregate of 803,572 Class B ordinary shares subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised in full or in part. As of June 30, 2026, following underwriter’s full exercise of over-allotment option on June 5, 2026, no Class B ordinary shares were subject to forfeiture.
[2]	On May 12, 2026, the Sponsor surrendered 6,160,714 founder shares to the Company for no consideration, which shares were cancelled, resulting in an aggregate of 6,160,715 founder shares outstanding. All shares and associated amounts have been retroactively restated to reflect the surrender (see Note 5).

Condensed Statements of Cash Flows (Unaudited)	6 Months Ended
Condensed Statements of Cash Flows (Unaudited)	Jun. 30, 2026 USD ($)
Cash flows from Operating Activities:
Net Income	$ 208,319
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Interest income on cash held in trust account	(372,790)
Formation and operating costs paid by Sponsor from Promissory Note – a related party	87,609
Change in operating assets and liabilities
Prepaid expense	(140,477)
Net cash used in operating activities	(217,339)
Cash flow from Investing Activities:
Investment of cash in trust account	(143,750,000)
Net cash used in Investing Activities	(143,750,000)
Cash flow from Financing Activities:
Proceeds from Initial Public Offering	143,750,000
Proceeds from sale of private placement units	2,075,000
Payment of cash underwriting fee (including payments to underwriting counsel)	(1,180,000)
Payment of accrued offering costs	(374,916)
Net cash provided by Financing Activities	144,270,084
Net Change in Cash	302,745
Cash – Beginning of period
Cash – End of period	302,745
Supplemental Disclosures of Noncash Investing and Financing Activities
Deferred offering costs included in accrued offering costs	343,416
Deferred offering costs included in promissory note	154,631
Deferred offering costs included in advance from related party	21,654
Deferred underwriting fee	4,312,500
Remeasurement of Class A ordinary share at Initial Public Offering	16,530,933
Remeasurement to Accumulated Deficit	3,661,852
Accretion to redemption value	372,790
Promissory note in exchange for private units	$ 550,000

Condensed Balance Sheet - USD ($)

Jun. 30, 2026

Dec. 31, 2025

Current Assets

Cash

$ 302,745

Prepaid expenses

140,477

Deferred offering costs

299,009

Total Current Assets

443,222

299,009

Cash held in trust account

144,122,790

Total Assets

144,566,012

299,009

Current Liabilities

Accrued offering costs

3,500

35,000

Promissory note – related party

307,760

Total Current Liabilities

25,154

342,760

Deferred Underwriting Fee

4,312,500

Total Liabilities

4,337,654

342,760

Commitments and Contingencies (Note 6)

Class A ordinary shares subject to redemption, $0.0001 par value; 450,000,000 shares authorized; 14,375,000 shares issued and outstanding, at redemption price $10.03 as of June 30, 2026

144,122,790

Shareholders’ Deficit

Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding

Additional paid-in capital

24,384

Accumulated Deficit

(3,870,133)

(43,751)

Subscription receivable

(25,000)

Total Shareholders’ Deficit

(3,894,432)

(43,751)

Total Liabilities, Redeemable Ordinary Shares and Shareholders’ Deficit

144,566,012

299,009

Common Class A [Member]

Shareholders’ Deficit

Ordinary shares

Common Class B [Member]

Shareholders’ Deficit

Ordinary shares

^[1],[2]

616

Related Party [Member]

Current Liabilities

Advance from related party

$ 21,654

[1]	Includes an aggregate of 803,572 Class B ordinary shares subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised in full or in part. As of June 30, 2026, following underwriter’s full exercise of over-allotment option on June 5, 2026, no Class B ordinary shares were subject to forfeiture.
[2]	On May 12, 2026, the Sponsor surrendered 6,160,714 founder shares to the Company for no consideration, which shares were cancelled, resulting in an aggregate of 6,160,715 founder shares outstanding. All shares and associated amounts have been retroactively restated to reflect the surrender (see Note 5).